Financial Reports Latest Updates Industry Maps Economic Calendar

Evolus, Inc. (EOLS) Annual Reports

Q: Where can I read Evolus, Inc. (EOLS) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Evolus, Inc. is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1570562 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$84.1M	$69.4M	+21.2%
Operating income	$-4.5M	$-10.2M	+55.5%
Net income	$-8.1M	$-17.1M	+53.0%
EPS (diluted)	$-0.12	$-0.27	+55.6%

Company guidance
	Period	Range
Adjusted EBITDA	—	$450M – $500M
Adjusted EBITDA	Q2 2026	$330M – $337M
Revenue	FY2026	$330M – $337M

Figures are the company’s own outlook as stated in its earnings release, not analyst estimates.

Source: SEC EDGAR (XBRL company facts); guidance from Form 8-K Exhibit 99.1

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 84.1 mn Net income -8.05 mn

Show table：Income statement

Item	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	—	—	—	0	0	0	0	2.31	13.2	19.4	10.5	7.81	17.7	20.6	12.2	26.1	26.7	34.7	33.9	37.2	33.9	43.6	41.7	49.4	50.0	61.0	59.3	66.9	61.1	79.0	68.5	69.4	69.0	90.3	73.1	84.1
Gross profit	—	—	—	—	—	0	0	0	0	1.65	9.45	15.8	6.28	5.86	12.8	—	—	—	—	—	—	—	—	89.8	—	—	—	138	40.5	47.1	42.1	52.6	46.7	45.3	45.8	59.3	48.9	57.2
Operating income	-3.98	-2.27	-2.62	-2.86	-6.04	-16.1	-11.5	-12.5	-25.3	-36.0	-25.1	-12.5	-17.4	-18.9	-8.76	-108	8.01	-15.3	-19.1	-18.0	-15.4	-21.4	-17.9	-10.6	-12.0	-15.1	-13.4	-8.63	-8.92	-7.70	-15.5	-2.31	-15.2	-10.2	-11.5	4.22	-6.85	-4.54
Net income	-4.00	-2.30	-2.63	4.45	-6.16	-16.4	-11.8	-12.4	-11.0	-37.6	-27.0	-14.5	-19.7	-21.1	-11.5	-111	6.40	-15.6	-19.4	-18.2	-17.5	-23.5	-20.3	-13.2	-14.8	-18.1	-16.9	-11.8	-13.1	-11.3	-19.2	-6.79	-18.9	-17.1	-15.7	0.13	-10.7	-8.05

Balance sheet

Quarterly · In mn (USD)

Total assets 248 mn Total liabilities 279 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	72.8	50.1	44.6	106	94.3	139	116	95.2	152	126	108	132	128	77.7	162	138	179	143	134	116	101	84.1	96.5	92.0	112	150	158	150	151	132	145	135	143	139	168
Total assets	—	—	—	152	127	122	183	172	221	203	183	240	214	195	216	209	157	240	215	257	221	211	193	178	160	169	168	189	226	234	230	233	213	229	219	226	221	248
Current liabilities	—	—	—	213	3.63	3.68	5.46	5.28	9.40	23.1	26.0	24.4	22.6	19.5	12.7	180	87.7	87.3	71.3	57.7	40.7	51.5	51.3	46.5	40.7	41.4	48.5	48.3	46.8	54.1	60.8	63.0	56.2	63.8	66.7	75.3	68.0	98.7
Total liabilities	—	—	—	228	75.4	84.0	88.4	87.5	146	162	166	161	152	151	181	282	134	134	118	176	153	164	164	159	153	176	187	210	208	214	224	227	220	247	248	249	249	279
Equity	—	—	—	-75.5	52.0	37.9	95.0	84.4	75.4	41.2	17.0	79.5	62.6	43.6	35.1	-73.0	23.3	106	97.4	81.9	67.3	46.9	29.2	18.5	6.95	-6.96	-19.4	-20.7	18.4	19.3	5.89	5.52	-6.60	-18.6	-28.8	-23.1	-28.8	-30.9

Cash flow

Quarterly · In mn (USD)

Operating -3.59 mn Investing -0.5 mn Financing -0.36 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-5.58	-3.21	-3.43	-1.00	-2.20	-5.66	-5.80	-12.0	-19.2	-33.2	-25.1	-15.9	-27.9	-13.9	-13.7	-2.27	-8.34	16.1	-32.1	-9.04	-38.2	-20.9	-17.1	-8.77	-20.6	-13.3	-0.92	0.81	-10.6	-6.47	-5.72	4.81	-15.6	-24.8	-14.7	12.8	-9.95	-3.59
Investing	—	0	0	0	0	-0.01	0	0	-80.0	8.23	34.4	14.0	-46.2	9.38	29.3	19.7	4.79	-0.39	0.02	-0.39	-0.26	-0.39	-0.9	-1.39	-0.51	-0.22	-0.54	-0.36	-0.8	-1.25	-1.41	-1.36	-1.86	-2.27	-2.16	-2.17	-1.69	-0.5
Financing	5.39	3.21	3.43	1.00	51.8	-0.31	67.4	0	60.4	0.85	-0.46	72.7	-1.10	-0.31	39.8	0	-76.8	93.8	8.16	47.9	-1.02	-0.85	-0.76	-1.52	-1.28	23.8	-1.42	23.5	45.7	4.48	-1.42	-1.31	-1.63	20.7	-1.77	0.08	7.62	-0.36
Cash at period end	0	0	0	0	49.6	43.6	105	93.2	54.4	30.3	39.1	110	34.6	29.8	85.1	103	22.2	132	108	146	107	84.5	65.6	53.9	31.5	41.7	38.7	62.8	97.0	93.7	85.0	87.0	67.9	61.7	43.5	53.8	49.8	45.2

Profitability

Quarterly · %

Gross margin 68.0% Operating margin -5.4% Net margin -9.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	—	—	—	—	—	—	—	—	—	71.4%	71.8%	81.3%	59.8%	75.0%	72.5%	—	—	—	—	—	—	—	—	205.7%	—	—	—	225.5%	68.3%	70.3%	68.9%	66.7%	68.1%	65.3%	66.5%	65.7%	66.9%	68.0%
Operating margin	—	—	—	—	—	—	—	—	—	-1557.6%	-190.9%	-64.5%	-165.7%	-241.9%	-49.6%	-525.0%	65.5%	-58.6%	-71.7%	-51.9%	-45.6%	-57.4%	-52.8%	-24.4%	-28.9%	-30.6%	-26.9%	-14.2%	-15.0%	-11.5%	-25.3%	-2.9%	-22.1%	-14.7%	-16.7%	4.7%	-9.4%	-5.4%
Net margin	—	—	—	—	—	—	—	—	—	-1625.6%	-204.9%	-74.6%	-188.0%	-270.6%	-64.9%	-538.0%	52.3%	-59.8%	-72.8%	-52.5%	-51.6%	-63.2%	-59.8%	-30.2%	-35.5%	-36.8%	-33.8%	-19.4%	-22.1%	-17.0%	-31.4%	-8.6%	-27.6%	-24.7%	-22.8%	0.1%	-14.6%	-9.6%

Returns & leverage

Quarterly · %

ROE -18729.6% ROA -14.4% Debt ratio 112.5%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	-12.8%	-54.8%	-31.6%	-1060.2%	-81.2%	-184.1%	-157.1%	-109.9%	-143.2%	-194.3%	-256.4%	-5016.6%	-318.7%	-175.4%	-210.3%	-1049.8%	-156.2%	-102.7%	-125.5%	-148.3%	-193.3%	-332.7%	-1279.3%	—	-472.6%	-861.7%	—	—	-949.5%	-18729.6%	—	—	—	—
ROA	—	—	—	-2.9%	-5.2%	-17.0%	-16.4%	-28.9%	-29.7%	-44.9%	-48.1%	-43.7%	-45.4%	-41.5%	-33.5%	-72.5%	-73.7%	-60.5%	-64.7%	-20.1%	-37.4%	-34.9%	-38.9%	-34.2%	-37.6%	-34.9%	-34.9%	-33.6%	-31.1%	-26.4%	-27.9%	-23.9%	-25.6%	-26.8%	-26.1%	-22.5%	-20.0%	-14.4%
Debt ratio	—	—	—	149.6%	59.2%	68.9%	48.2%	50.9%	65.9%	79.7%	90.7%	67.0%	70.8%	77.6%	83.7%	134.9%	85.2%	55.8%	54.7%	68.2%	69.5%	77.8%	84.8%	89.6%	95.7%	104.1%	111.5%	111.0%	91.8%	91.7%	97.4%	97.6%	103.1%	108.2%	113.1%	110.2%	113.0%	112.5%

EPS

Quarterly · US$

EPS US$-0.12

Show table：EPS

Item	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	—	—	—	—	—	—	—	-0.59	-0.63	-0.34	-3.28	0.16	-0.31	-0.35	-0.34	-0.31	-0.42	-0.36	-0.24	-0.26	-0.32	-0.30	-0.20	-0.22	-0.18	-0.30	-0.10	-0.30	-0.27	-0.24	0.00	-0.16	-0.12

Revenue & profit

Year-to-date · In mn (USD)

Revenue 157 mn Net income -18.7 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 248 mn Total liabilities 279 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -13.5 mn Investing -2.19 mn Financing 7.25 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 67.5% Operating margin -7.3% Net margin -11.9%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -18729.6% ROA -14.4% Debt ratio 112.5%

EPS

Year-to-date · US$

EPS US$-0.28

Revenue & profit

Annual · In mn (USD)

Revenue 297 mn Net income -51.6 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	—	—	34.9	56.5	99.7	149	202	266	297
Gross profit	—	—	26.9	—	—	—	—	182	197
Operating income	-11.7	-46.1	-99.0	-153	-44.4	-65.3	-49.2	-34.4	-32.7
Net income	-4.48	-46.9	-90.0	-163	-46.8	-74.4	-61.7	-50.4	-51.6

Balance sheet

Annual · In mn (USD)

Total assets 226 mn Total liabilities 249 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	72.8	94.3	152	128	179	101	112	151	143
Total assets	152	172	240	209	257	178	189	233	226
Current liabilities	213	5.28	24.4	180	57.7	46.5	48.3	63.0	75.3
Total liabilities	228	87.5	161	282	176	159	210	227	249
Equity	-75.5	84.4	79.5	-73.0	81.9	18.5	-20.7	5.52	-23.1

Cash flow

Annual · In mn (USD)

Operating -42.3 mn Investing -8.45 mn Financing 17.3 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-13.2	-25.7	-93.4	-57.9	-33.4	-84.9	-34.0	-18.0	-42.3
Investing	—	-0.01	-23.4	12.2	4.03	-2.94	-1.63	-4.82	-8.45
Financing	13.0	119	134	38.4	73.0	-4.15	44.6	47.4	17.3
Cash at period end	0	93.2	110	103	146	53.9	62.8	87.0	53.8

Profitability

Annual · %

Gross margin 66.3% Operating margin -11.0% Net margin -17.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	—	—	77.0%	—	—	—	—	68.5%	66.3%
Operating margin	—	—	-283.3%	-270.7%	-44.5%	-44.0%	-24.4%	-12.9%	-11.0%
Net margin	—	—	-257.8%	-288.3%	-47.0%	-50.1%	-30.5%	-18.9%	-17.4%

Returns & leverage

Annual · %

ROE -148.3% ROA -22.5% Debt ratio 110.2%

Show table：Returns & leverage

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	—	-1060.2%	-109.9%	-5016.6%	-1049.8%	-148.3%	—	—	—
ROA	-2.9%	-28.9%	-43.7%	-72.5%	-20.1%	-34.2%	-33.6%	-23.9%	-22.5%
Debt ratio	149.6%	50.9%	67.0%	134.9%	68.2%	89.6%	111.0%	97.6%	110.2%

EPS

Annual · US$

EPS US$-0.81

Show table：EPS

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	-4.84	-0.84	-1.33	-1.08	-0.80	-0.81

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Evolus, Inc. (EOLS) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.